156 related articles for article (PubMed ID: 22669160)
41. Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC).
Tang Z; Shen Q; Xie H; Zhou X; Li J; Feng J; Liu H; Wang W; Zhang S; Ni S
Oncotarget; 2016 Jul; 7(29):46253-46262. PubMed ID: 27323829
[TBL] [Abstract][Full Text] [Related]
42. Tumour cell and stromal features in metastatic and non-metastatic non-small cell lung carcinomas.
Minamoto H; Antonângelo L; da Silva AG; Gallo CP; de Andrade e Silva FB; Fenezelian S; Rodrigues OR; Jatene F; Saldiva P; Capelozzi VL
Histopathology; 2003 Nov; 43(5):427-43. PubMed ID: 14636269
[TBL] [Abstract][Full Text] [Related]
43. [Expression of Fas, Fas ligand, Fas-associated death domain protein, caspase 8 and mutant P53 protein in esophageal squamous cell carcinoma].
Xue LY; Ren LQ; Luo W; Guan XJ; Zou SM; Zheng S; Bi R; Xie YQ; He ZG; Lü N
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):150-4. PubMed ID: 17425843
[TBL] [Abstract][Full Text] [Related]
44. Expression of CDK5/p35 in resected patients with non-small cell lung cancer: relation to prognosis.
Liu JL; Wang XY; Huang BX; Zhu F; Zhang RG; Wu G
Med Oncol; 2011 Sep; 28(3):673-8. PubMed ID: 20354813
[TBL] [Abstract][Full Text] [Related]
45. Activating enhancer-binding protein-2β nucleolar localization predicts poor survival after stage I non-small cell lung cancer resection.
Kim MP; Chen Y; Bekele BN; Lopez A; Khanna A; Chen JQ; Spitz MR; Behrens C; Solis L; Wismach M; Ji L; Wistuba II; Roth JA; Katz RL
Ann Thorac Surg; 2011 Sep; 92(3):1044-50. PubMed ID: 21871297
[TBL] [Abstract][Full Text] [Related]
46. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
47. Krüppel-Like Factor 8 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
Li J; Liu Y; Xue J; Xu M; Zhang J; Liu J; Wang W
Pathol Oncol Res; 2019 Jan; 25(1):115-121. PubMed ID: 28986741
[TBL] [Abstract][Full Text] [Related]
48. Overexpression of MAC30 is associated with poor clinical outcome in human non-small-cell lung cancer.
Han KY; Gu X; Wang HR; Liu D; Lv FZ; Li JN
Tumour Biol; 2013 Apr; 34(2):821-5. PubMed ID: 23229099
[TBL] [Abstract][Full Text] [Related]
49. Integrin αvβ5 as a biomarker for the assessment of non-small cell lung cancer metastasis and overall survival.
Bai SY; Xu N; Chen C; Song YL; Hu J; Bai CX
Clin Respir J; 2015 Oct; 9(4):457-67. PubMed ID: 24815623
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
51. HSP90B1 overexpression predicts poor prognosis in NSCLC patients.
Xu Y; Chen Z; Zhang G; Xi Y; Sun R; Wang X; Wang W; Chai F; Li X
Tumour Biol; 2016 Oct; 37(10):14321-14328. PubMed ID: 27599983
[TBL] [Abstract][Full Text] [Related]
52. Absence or low expression of fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome.
Tourneur L; Delluc S; Lévy V; Valensi F; Radford-Weiss I; Legrand O; Vargaftig J; Boix C; Macintyre EA; Varet B; Chiocchia G; Buzyn A
Cancer Res; 2004 Nov; 64(21):8101-8. PubMed ID: 15520222
[TBL] [Abstract][Full Text] [Related]
53. High SYT7 expression is associated with poor prognosis in human non-small cell lung carcinoma.
Han Q; Zou D; Lv F; Wang S; Yang C; Song J; Wen Z; Zhang Y
Pathol Res Pract; 2020 Sep; 216(9):153101. PubMed ID: 32825966
[TBL] [Abstract][Full Text] [Related]
54. Loss of Bad expression confers poor prognosis in non-small cell lung cancer.
Huang Y; Liu D; Chen B; Zeng J; Wang L; Zhang S; Mo X; Li W
Med Oncol; 2012 Sep; 29(3):1648-55. PubMed ID: 21918885
[TBL] [Abstract][Full Text] [Related]
55. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].
Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277
[TBL] [Abstract][Full Text] [Related]
56. [Correlation of KLF4 and SPARC expression with the clinical characteristics of non-small cell lung cancer].
Zhang Z; Wang Z; Liu X; Shi M; Chen G; Zhang B; Li Z; Song L
Zhongguo Fei Ai Za Zhi; 2012 Dec; 15(12):720-4. PubMed ID: 23249717
[TBL] [Abstract][Full Text] [Related]
57. Correlation between loss of Smad4 and clinical parameters of non-small cell lung cancer: an observational cohort study.
Guo X; Li M; Wang X; Pan Y; Li J
BMC Pulm Med; 2021 Apr; 21(1):111. PubMed ID: 33794845
[TBL] [Abstract][Full Text] [Related]
58. Prognostic value of ERCC1, RRM1, BRCA1 and SETDB1 in early stage of non-small cell lung cancer.
Lafuente-Sanchis A; Zúñiga Á; Galbis JM; Cremades A; Estors M; Martínez-Hernández NJ; Carretero J
Clin Transl Oncol; 2016 Aug; 18(8):798-804. PubMed ID: 26542178
[TBL] [Abstract][Full Text] [Related]
59. High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.
Wei LX; Zhou RS; Xu HF; Wang JY; Yuan MH
Tumour Biol; 2013 Apr; 34(2):941-6. PubMed ID: 23264086
[TBL] [Abstract][Full Text] [Related]
60. Comparison of cofilin‑1 and Twist‑1 protein expression in human non‑small cell lung cancer tissues.
Chang CY; Chang SL; Leu JD; Chang YC; Hsiao M; Lin LT; Lin HN; Lee YJ
Oncol Rep; 2019 Aug; 42(2):805-816. PubMed ID: 31233187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
